<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="3787546 doi: 10.3389/fmicb.2013.00293 : Microbiology: Review Article Virus-induced exacerbations in" exact="asthma" post="and COPD Kurai Daisuke * Saraya Takeshi * Ishii"/>
 <result pre="characterized by chronic airway inflammation and/or airflow limitation due to" exact="pulmonary emphysema." post="Chronic bronchitis, pulmonary emphysema, and bronchial asthma may all"/>
 <result pre="inflammation and/or airflow limitation due to pulmonary emphysema. Chronic bronchitis," exact="pulmonary emphysema," post="and bronchial asthma may all be associated with airflow"/>
 <result pre="due to pulmonary emphysema. Chronic bronchitis, pulmonary emphysema, and bronchial" exact="asthma" post="may all be associated with airflow limitation; therefore, exacerbation"/>
 <result pre="may all be associated with airflow limitation; therefore, exacerbation of" exact="asthma" post="may be associated with the pathophysiology of COPD. Furthermore,"/>
 <result pre="associated with a wide variety of respiratory viruses. COPD and" exact="asthma" post="have different underlying pathophysiological processes and thus require individual"/>
 <result pre="increased mortality. Similar pathogens, including human rhinovirus, respiratory syncytial virus," exact="influenza" post="virus, parainfluenza virus, and coronavirus, are also frequently detected"/>
 <result pre="virus, and coronavirus, are also frequently detected during exacerbation of" exact="asthma" post="and/or COPD. Immune response to respiratory viral infections, which"/>
 <result pre="and differences of clinical features in patients with COPD and/or" exact="asthma" post="associated with respiratory viral infections, especially in the exacerbative"/>
 <result pre="to summarize current knowledge concerning exacerbation of both COPD and" exact="asthma" post="by focusing on the clinical significance of associated respiratory"/>
 <result pre="focusing on the clinical significance of associated respiratory virus infections." exact="asthma" post="COPD respiratory virus exacerbation overlap syndrome human rhinovirus respiratory"/>
 <result pre="virus fig-count: table-count: equation-count: ref-count: page-count: word-count: INTRODUCTION Asthma and" exact="chronic obstructive pulmonary disease" post="(COPD) are very common inflammatory diseases of the airways."/>
 <result pre="of the airways. The World Health Organization (WHO) estimates that" exact="asthma" post="accounts for 1 in every 250 deaths worldwide ("/>
 <result pre="every 250 deaths worldwide ( O’Sullivan, 2005). The prevalence of" exact="asthma" post="in developed countries is approximately 10% in adults and"/>
 <result pre="in the world by 2020 (Global initiative for chronic obstructive" exact="lung disease" post="[GOLD], 2013 1 ). Acute deterioration of symptoms and"/>
 <result pre="deterioration of symptoms and lung function, which often results in" exact="respiratory failure," post="is a so-called &quot;exacerbation,&quot; and it is an important"/>
 <result pre="adults and a major cause of exacerbations in patients with" exact="asthma" post="( Figure 1 ) and/or COPD ( Figure 2"/>
 <result pre="Figure 2 ). FIGURE 1 Human respiratory pathogens associated with" exact="asthma" post="exacerbations. Pathogens are divided into three categories as bacteria,"/>
 <result pre="review aims to summarize the clinical aspects of exacerbations in" exact="asthma" post="and COPD from the perspective of the definition of"/>
 <result pre="of airflow limitation is incomplete in COPD, while that in" exact="asthma" post="can be complete. Airway inflammation in asthma is characterized"/>
 <result pre="while that in asthma can be complete. Airway inflammation in" exact="asthma" post="is characterized by allergic phenotypes, such as dense infiltration"/>
 <result pre="such as smoking. With respect to the site of inflammation," exact="asthma" post="involves predominantly larger airways, while in COPD, inflammation affects"/>
 <result pre="bronchial biopsied specimens as well as eosinophils in severe refractory" exact="asthma" post="( Wenzel et al., 1999). DIFFERENCES AND SIMILARITIES BETWEEN"/>
 <result pre="DIFFERENCES AND SIMILARITIES BETWEEN ASTHMA AND COPD As described above," exact="asthma" post="is typically characterized by chronic allergic inflammatory airway inflammation"/>
 <result pre="airflow limitation that is usually progressive and ultimately results in" exact="respiratory failure." post="Therefore, it is not difficult to differentiate clinically between"/>
 <result pre="between the two disorders. However, determining whether a patient has" exact="asthma" post="or an exacerbation of COPD is often difficult, because"/>
 <result pre="auscultation, special maneuvers, and vital signs. Table 1 Differences between" exact="asthma" post="and COPD. Asthma COPD Age at onset At any"/>
 <result pre="sound of an expiratory wheeze is identical in asthma, COPD," exact="congestive heart failure," post="and pneumonia, and it cannot be used to distinguish"/>
 <result pre="with no consensus about it. There are many similarities in" exact="asthma" post="and COPD ( Bleecker, 2004), and previous studies suggested"/>
 <result pre="and COPD ( Bleecker, 2004), and previous studies suggested that" exact="asthma" post="may be a risk factor for the development of"/>
 <result pre="COPD ( Silva et al., 2004), while the coexistence of" exact="asthma" post="and COPD, so-called &quot;overlap syndrome,&quot; has recently been attracting"/>
 <result pre="et al., 2011). Furthermore, previous reports noted that exacerbations of" exact="asthma" post="or COPD are associated with accelerated loss of lung"/>
 <result pre="is crucial to recognize and understand the clinical features of" exact="asthma" post="and COPD patients, not only in the stable phase,"/>
 <result pre="viral infections. Johnston and Sears (2006) reported that exacerbations of" exact="asthma" post="and COPD appear to have a seasonal predilection in"/>
 <result pre="healthy participants (8.5%) were similar. The term virus-induced exacerbation of" exact="asthma" post="is not uncommon, but only a small number of"/>
 <result pre="condition in adult asthmatic patients. FIGURE 3 Multidisciplinary assessment for" exact="asthma" post="exacerbation. PCR, polymerase-chain reaction; RT-PCR, real-time PCR; BALF, bronchoalveolar"/>
 <result pre="SABA, short-acting β-agonist inhalers; GINA, Global Initiative for Asthma; ABPA," exact="allergic bronchopulmonary aspergillosis;" post="EPR, expert panel report. Definitions of acute exacerbation of"/>
 <result pre="aspergillosis; EPR, expert panel report. Definitions of acute exacerbation of" exact="asthma" post="The diagnosis of asthma is usually defined based on"/>
 <result pre="report. Definitions of acute exacerbation of asthma The diagnosis of" exact="asthma" post="is usually defined based on history and variability of"/>
 <result pre="therapy or spontaneously. There is no clear consensus definition for" exact="asthma" post="exacerbation; clinical trials usually define a severe exacerbation as"/>
 <result pre="to the latest NIH National Asthma Education and Prevention Guidelines," exact="asthma" post="exacerbations are acute or subacute episodes of progressively worsening"/>
 <result pre="asthma exacerbations are acute or subacute episodes of progressively worsening" exact="shortness" post="of breath, cough, wheezing, and chest tightness, or some"/>
 <result pre="American Thoracic Society and European Respiratory Society has recently defined" exact="asthma" post="exacerbations as events characterized by a change from the"/>
 <result pre="due to being outside the patient’s usual range of day-to-day" exact="asthma" post="variation. Mild exacerbations are not defined because such events"/>
 <result pre="defined because such events can be indistinguishable from loss of" exact="asthma" post="control ( Reddel et al., 2009; Figure 3 )."/>
 <result pre="female than in male patients, and the higher prevalence of" exact="asthma" post="in adult women contrasts with the higher prevalence of"/>
 <result pre="asthma in adult women contrasts with the higher prevalence of" exact="asthma" post="in male children ( Bjornson and Mitchell, 2000). Between"/>
 <result pre="Bjornson and Mitchell, 2000). Between 14 and 45% of acute" exact="asthma" post="exacerbations in children is thought to be related to"/>
 <result pre="is less clear, previous reports showed that RTIs associated with" exact="asthma" post="exacerbation in adults ranged from 10–21% ( Teichtahl et"/>
 <result pre="suggest that viral infections are involved in about 50% of" exact="asthma" post="exacerbations among adults and in probably substantially more childhood"/>
 <result pre="asthma exacerbations among adults and in probably substantially more childhood" exact="asthma" post="exacerbations. Another report also showed that the virus most"/>
 <result pre="report also showed that the virus most commonly implicated in" exact="asthma" post="exacerbations appears to be HRV ( Murray et al.,"/>
 <result pre="other respiratory tract viruses, such as respiratory syncytial virus (RSV)," exact="influenza" post="viruses, coronaviruses, human metapneumoviruses (HMPVs), parainfluenza viruses (PIVs), adenoviruses"/>
 <result pre="(AdVs), and bocaviruses, have all been detected in subjects with" exact="asthma" post="exacerbations ( Jackson and Johnston, 2010). In adults requiring"/>
 <result pre="2010). In adults requiring hospital admission for an acute severe" exact="asthma" post="exacerbation in a 1-year period, virus was identified in"/>
 <result pre="was identified in 29% of the subjects, with HRV and" exact="influenza" post="A the most commonly identified infectious agents ( Teichtahl"/>
 <result pre="that nasopharyngeal secretions and induced sputum during acute exacerbations of" exact="asthma" post="in adult patients were equal, while Falsey et al."/>
 <result pre="largely cell-associated ( Murray et al., 2004). Causes of acute" exact="asthma" post="exacerbations Eczema and a family history of asthma are"/>
 <result pre="of acute asthma exacerbations Eczema and a family history of" exact="asthma" post="are the dominant non-infectious risk factors for pediatric asthma,"/>
 <result pre="of adult-onset disease are less well defined. The causes for" exact="asthma" post="exacerbation have been described and categorized. Of note, clinicians"/>
 <result pre="should recognize the seasonal trends for exacerbations of wheezing or" exact="asthma" post="in adults, which occur 1–2 weeks later than in"/>
 <result pre="1 ). Viruses . The most important viruses relevant to" exact="asthma" post="development are RSV and HRV. Jackson et al. (2008)"/>
 <result pre="a large, high-risk cohort, children had an increased risk of" exact="asthma" post="at 6 years of age if they wheezed in"/>
 <result pre="1995). The exact mechanisms by which respiratory viral infection causes" exact="asthma" post="exacerbation remains to be determined, but the respiratory viruses"/>
 <result pre="role of severe RSV infection as a risk factor for" exact="asthma" post="in adulthood is less certain, but it is still"/>
 <result pre="young children and accounts for ~70% of severe infantile viral" exact="bronchiolitis" post="and/or pneumonia cases, most of whom have wheezing, and"/>
 <result pre="and accounts for ~70% of severe infantile viral bronchiolitis and/or" exact="pneumonia" post="cases, most of whom have wheezing, and it is"/>
 <result pre="Furthermore, this study showed the strongest evidence that human RSV-mediated" exact="bronchiolitis" post="has long-term effects using palivizumab (a humanized monoclonal antibody"/>
 <result pre="the most common pathogens, whereas in older children, rhinovirus and" exact="influenza" post="A virus are more prevalent ( Beasley et al.,"/>
 <result pre="Beasley et al., 1988). Even in elderly persons, RSV causes" exact="pneumonia" post="( Falsey et al., 2006), exacerbations of COPD, and"/>
 <result pre="infection with HRV as a predominant respiratory pathogen associated with" exact="asthma" post="later in life ( Kusel et al., 2007). HRV"/>
 <result pre="is the most important virus type associated with exacerbations of" exact="asthma" post="leading to hospital admission in both adults and children"/>
 <result pre="and AdV were most commonly identified in near-fatal asthma, whereas" exact="influenza" post="virus predominated in COPD. Corne et al. (2002) found"/>
 <result pre="children. AdVs are associated with up to 7% of virus-related" exact="asthma" post="exacerbations ( McErlean et al., 2010), and they cause"/>
 <result pre="variety of clinical syndromes, such as diarrhea, keratoconjunctivitis, and hemorrhagic" exact="cystitis" post="( Brodzinski and Ruddy, 2009). It has been demonstrated"/>
 <result pre="It has been demonstrated that 94% of children with refractory" exact="asthma" post="has detectable AdV antigens, compared with 0% of controls"/>
 <result pre="noted, PIV is one of the most common pathogens for" exact="asthma" post="exacerbation in children under 5 years. In adults with"/>
 <result pre="department ( Atmar et al., 1998). Other viruses . Most" exact="asthma" post="studies describe relatively low levels of influenza viruses in"/>
 <result pre="viruses . Most asthma studies describe relatively low levels of" exact="influenza" post="viruses in asthmatic patients with exacerbations, approximately 1–9% of"/>
 <result pre="in asthmatic patients with exacerbations, approximately 1–9% of all virus-related" exact="asthma" post="exacerbations. Several studies indicated that human bocaviruses ( Gendrel"/>
 <result pre="are found more frequently in the airways of patients with" exact="asthma" post="than in healthy patients ( Nisar et al., 2007),"/>
 <result pre="been shown to increase mucus secretion, which is recognized in" exact="asthma" post="or COPD by characteristic goblet cell hyperplasia or enhanced"/>
 <result pre="al., 2007; Kraft et al., 2008). Fungus . Allergic bronchopulmonary" exact="aspergillosis" post="(ABPA) is a unique form of asthma caused by"/>
 <result pre=". Allergic bronchopulmonary aspergillosis (ABPA) is a unique form of" exact="asthma" post="caused by colonization of the LRT ( Vlahakis and"/>
 <result pre="mold Aspergillus spp., by which colonization leads to allergic and/or" exact="asthma" post="symptoms ( Edwards et al., 2012). Other factors ."/>
 <result pre="et al., 2012). Other factors . The diverse etiologies for" exact="asthma" post="exacerbation are well known, including viruses, allergens (dust mite,"/>
 <result pre="pollutants. Physicians should be aware of these risk factors for" exact="asthma" post="exacerbation ( Dougherty and Fahy, 2009). Mechanisms of viral-induced"/>
 <result pre="asthma exacerbation ( Dougherty and Fahy, 2009). Mechanisms of viral-induced" exact="asthma" post="exacerbations Respiratory virus infection affects the pathogenesis of asthma."/>
 <result pre="these patients remain unknown. Virus-associated clinical symptoms and exacerbations of" exact="asthma" post="In general, upper respiratory tract (URT) symptoms include rhinorrhea,"/>
 <result pre="fever, while LRT symptoms include symptoms such as wheeze, cough," exact="shortness" post="of breath, and chest tightness ( Corne et al.,"/>
 <result pre="pathogens were implicated in almost half of the most severe" exact="asthma" post="exacerbations with a &amp;gt; 50 L/min mean decrease in"/>
 <result pre="found that URT infections were strongly associated with exacerbations of" exact="asthma" post="leading to hospital admission, in both adults and children"/>
 <result pre="Johnston et al., 1996), and they may have contributed to" exact="asthma" post="mortality, especially in the setting of hospital admission. Specific"/>
 <result pre="admission. Specific anti-viral therapies have not been established except for" exact="influenza" post="viral infection, which have been recommended for persons with"/>
 <result pre="influenza viral infection, which have been recommended for persons with" exact="asthma" post="or COPD. Furthermore, regarding preventive therapy for RSV, palivizumab"/>
 <result pre="it might be appropriate for infants and young children with" exact="congenital heart disease," post="bronchopulmonary dysplasia, and prematurity before 35 weeks of gestation"/>
 <result pre="might be appropriate for infants and young children with congenital" exact="heart disease," post="bronchopulmonary dysplasia, and prematurity before 35 weeks of gestation"/>
 <result pre="or steroids with or without admission. Diseases such as pneumonia," exact="congestive heart failure," post="and pulmonary embolism that mimic and/or aggravate exacerbations were"/>
 <result pre="without admission. Diseases such as pneumonia, congestive heart failure, and" exact="pulmonary embolism" post="that mimic and/or aggravate exacerbations were generally excluded from"/>
 <result pre="fall and winter in the same fashion as in adult" exact="asthma" post="( Johnston and Sears, 2006). CAUSES OF EXACERBATIONS It"/>
 <result pre="Moraxella catarrhalis, and P. aeruginosa) and respiratory viruses (HRV, RSV," exact="influenza" post="virus, HMPV, coronavirus, and AdVs) were recognized during exacerbations."/>
 <result pre="with exacerbation of COPD. Viruses such as HRV, RSV, and" exact="influenza" post="virus have a higher prevalence in patients with exacerbations"/>
 <result pre="viruses associated with exacerbations were HRV (3.1–26.6%), RSV (0.7–40.5%), and" exact="influenza" post="virus (2.0–22.4%; Seemungal et al., 2001; Rohde et al.,"/>
 <result pre="viruses detected during exacerbations of COPD were HRV, RSV, and" exact="influenza" post="virus, similar to those of asthma ( Tan et"/>
 <result pre="were HRV, RSV, and influenza virus, similar to those of" exact="asthma" post="( Tan et al., 2003). Other viruses, such as"/>
 <result pre="a key pro-allergic cytokine that has recently been linked to" exact="asthma" post="( Redhu and Gounni, 2012). In addition, genome-wide association"/>
 <result pre="TSLP gene were associated with various allergic diseases, including bronchial" exact="asthma" post="( Hirota et al., 2011; Ober and Yao, 2011)."/>
 <result pre="diseases ( Harper et al., 2009). A meta-analysis showed that" exact="influenza" post="vaccination prevented exacerbations in COPD patients ( Poole et"/>
 <result pre="disease ( Kaiser et al., 2003). Thus, treatment to prevent" exact="influenza" post="has been recommended for COPD patients ( Harper et"/>
 <result pre="prescribed, because specific anti-viral therapies do not exist, except for" exact="influenza" post="virus and RSV. Treatment for influenza appears appropriate in"/>
 <result pre="not exist, except for influenza virus and RSV. Treatment for" exact="influenza" post="appears appropriate in patients with COPD ( Harper et"/>
 <result pre="SUMMARY AT A GLANCE The associations between virus infections and" exact="asthma" post="and/or COPD were reviewed, and the significance of viral"/>
 <result pre="HRV and RSV are major causes of exacerbations both in" exact="asthma" post="and COPD patients. (2) The frequency of viral detection"/>
 <result pre="COPD patients. (2) The frequency of viral detection in both" exact="asthma" post="and COPD patients appears to be similar to that"/>
 <result pre="subjects, but the effect on their clinical course is different;" exact="asthma" post="and COPD patients tend to have more severe or"/>
 <result pre="function, and mortality may be increased. (3) Since discrimination between" exact="asthma" post="and COPD is difficult, especially during exacerbations, whenever clinicians"/>
 <result pre="is required for diagnosis. (4) The clinical findings of both" exact="asthma" post="and COPD, so-called &quot;overlap syndrome,&quot; are commonly recognized in"/>
 <result pre="Granulocyte inflammatory markers and airway infection during acute exacerbation of" exact="chronic obstructive pulmonary disease." post="Am. J. Respir. Crit. Care Med. 163 349– 355"/>
 <result pre="21680942 Barnes P. J. ( 2008). The cytokine network in" exact="asthma" post="and chronic obstructive pulmonary disease. J. Clin. Invest. 118"/>
 <result pre="P. J. ( 2008). The cytokine network in asthma and" exact="chronic obstructive pulmonary disease." post="J. Clin. Invest. 118 3546– 3556 10.1172/JCI36130 18982161 Beasley"/>
 <result pre="M. ( 1988). Viral respiratory tract infection and exacerbations of" exact="asthma" post="in adult patients. Thorax 43 679– 683 10.1136/thx.43.9.679 3194873"/>
 <result pre="B. Heilbronner C. et al. ( 2004). Mycoplasma pneumoniae and" exact="asthma" post="in children. Clin. Infect. Dis 38 1341– 1346 10.1086/392498"/>
 <result pre="Halkjaer L. B. Bonnelykke K. et al. ( 2007). Childhood" exact="asthma" post="after bacterial colonization of the airway in neonates. N."/>
 <result pre="Bjornson C. L. Mitchell I. ( 2000). Gender differences in" exact="asthma" post="in childhood and adolescence. J. Gend. Specif. Med. 3"/>
 <result pre="12149525 Bleecker E. R. ( 2004). Similarities and differences in" exact="asthma" post="and COPD. The Dutch hypothesis. Chest 126 93S– 95S"/>
 <result pre="2012). Viral stimuli trigger exaggerated thymic stromal lymphopoietin expression by" exact="chronic obstructive pulmonary disease" post="epithelium: role of endosomal TLR3 and cytosolic RIG-I-like helicases."/>
 <result pre="al. ( 2007). Salmeterol and fluticasone propionate and survival in" exact="chronic obstructive pulmonary disease." post="N. Engl. J. Med. 356 775– 789 10.1056/NEJMoa063070 17314337"/>
 <result pre="Ward M. E. ( 1998). Chronic Chlamydia pneumoniae infection and" exact="asthma" post="exacerbations in children. Eur. Respir. J. 11 345– 349"/>
 <result pre="et al. ( 2012). Viral epidemiology of acute exacerbations of" exact="chronic obstructive pulmonary disease." post="Pulm. Pharmacol. Ther. 25 12– 18 10.1016/j.pupt.2011.08.004 21983132 Donaldson"/>
 <result pre="2002). Relationship between exacerbation frequency and lung function decline in" exact="chronic obstructive pulmonary disease." post="Thorax 57 847– 852 10.1136/thorax.57.10.847 12324669 Dougherty R. H."/>
 <result pre="( 2006). Detection of respiratory syncytial virus in adults with" exact="chronic obstructive pulmonary disease." post="Am. J. Respir. Crit. Care Med. 173 639– 643"/>
 <result pre="( 2000). Respiratory viral infections in adults with and without" exact="chronic obstructive pulmonary disease." post="Am. J. Respir. Crit. Care Med. 162 167– 173"/>
 <result pre="Gravenstein S. Hayden F. G. et al. ( 2009). Seasonal" exact="influenza" post="in adults and children–diagnosis, treatment, chemoprophylaxis, and institutional outbreak"/>
 <result pre="et al. ( 1979). The etiologic and epidemiologic spectrum of" exact="bronchiolitis" post="in pediatric practice. J. Pediatr. 95 183– 190 10.1016/S0022-3476(79)80647-2"/>
 <result pre="Genome-wide association study identifies three new susceptibility loci for adult" exact="asthma" post="in the Japanese population. Nat. Genet. 43 893– 896"/>
 <result pre="et al. ( 2004). The nature of small-airway obstruction in" exact="chronic obstructive pulmonary disease." post="N. Engl. J. Med. 350 2645– 2653 10.1056/NEJMoa032158 15215480"/>
 <result pre="Tal-Singer R. et al. ( 2010). Susceptibility to exacerbation in" exact="chronic obstructive pulmonary disease." post="N. Engl. J. Med. 363 1128– 1138 10.1056/NEJMoa0909883 20843247"/>
 <result pre="al. ( 2008). Wheezing rhinovirus illnesses in early life predict" exact="asthma" post="development in high-risk children. Am. J. Respir. Crit. Care"/>
 <result pre="Community study of role of viral infections in exacerbations of" exact="asthma" post="in 9-11 year old children. BMJ 310 1225– 1229"/>
 <result pre="D. Kim H. Mcivor R. A. ( 2009). Diagnosis of" exact="asthma" post="in adults. CMAJ 181 E210– E220 10.1503/cmaj.080006 19770241 Keatings"/>
 <result pre="and tumor necrosis factor-alpha in induced sputum from patients with" exact="chronic obstructive pulmonary disease" post="or asthma. Am. J. Respir. Crit. Care Med. 153"/>
 <result pre="Beck E. Vandewalker M. et al. ( 2012). Tiotropium in" exact="asthma" post="poorly controlled with standard combination therapy. N. Engl. J."/>
 <result pre="900– 908 10.1378/chest.07-0530 17573516 Kraft M. ( 2006). Asthma and" exact="chronic obstructive pulmonary disease" post="exhibit common origins in any country! Am. J. Respir."/>
 <result pre="induces degradation of antimicrobial peptides and secondary bacterial infection in" exact="chronic obstructive pulmonary disease." post="Am. J. Respir. Crit. Care Med. 186 1117– 1124"/>
 <result pre="( 2011). Experimental rhinovirus infection as a human model of" exact="chronic obstructive pulmonary disease" post="exacerbation. Am. J. Respir. Crit. Care Med. 183 734–"/>
 <result pre="al. ( 2008). Rhinovirus-induced lower respiratory illness is increased in" exact="asthma" post="and related to virus load and Th1/2 cytokine and"/>
 <result pre="S. Simpson A. Custovic A. ( 2004). Allergens, viruses, and" exact="asthma" post="exacerbations. Proc. Am. Thorac. Soc. 1 99– 104 10.1513/pats.2306027"/>
 <result pre="B. Mullooly J. P. Hak E. ( 2007). Effectiveness of" exact="influenza" post="vaccine in the community-dwelling elderly. N. Engl. J. Med."/>
 <result pre="Ireland D. C. ( 1993). Respiratory viruses and exacerbations of" exact="asthma" post="in adults. BMJ 307 982– 986 10.1136/bmj.307.6910.982 8241910 Nisar"/>
 <result pre="Ober C. Yao T. C. ( 2011). The genetics of" exact="asthma" post="and allergic disease: a 21st century perspective. Immunol. Rev."/>
 <result pre="E. et al. ( 2010). Weekly monitoring of children with" exact="asthma" post="for infections and illness during common cold seasons. J."/>
 <result pre="monitoring of children with asthma for infections and illness during" exact="common cold" post="seasons. J. Allergy Clin. Immunol. 125 1001– 1006 e1."/>
 <result pre="Identification of human metapneumovirus and Chlamydophila pneumoniae in children with" exact="asthma" post="and wheeze in Singapore. Singapore Med. J. 48 291–"/>
 <result pre="G. et al. ( 2006). Infections and airway inflammation in" exact="chronic obstructive pulmonary disease" post="severe exacerbations. Am. J. Respir. Crit. Care Med. 173"/>
 <result pre="Cates C. J. ( 2000). Influenza vaccine for patients with" exact="chronic obstructive pulmonary disease." post="Cochrane Database Syst. Rev. CD002733 10.1002/14651858.CD002733 Rakes G. P."/>
 <result pre="( 2009). An official American Thoracic Society/European Respiratory Society statement:" exact="asthma" post="control and exacerbations: standardizing endpoints for clinical asthma trials"/>
 <result pre="Society statement: asthma control and exacerbations: standardizing endpoints for clinical" exact="asthma" post="trials and clinical practice. Am. J. Respir. Crit. Care"/>
 <result pre="S. ( 2012). Function and mechanisms of TSLP/TSLPR complex in" exact="asthma" post="and COPD. Clin. Exp. Allergy 42 994– 1005 10.1111/j.1365-2222.2011.03919.x"/>
 <result pre="A. et al. ( 2003). Respiratory viruses in exacerbations of" exact="chronic obstructive pulmonary disease" post="requiring hospitalisation: a case-control study. Thorax 58 37– 42"/>
 <result pre="Ruggieri M. P. Roggeri A. et al. ( 1994). Airway" exact="eosinophilia" post="in chronic bronchitis during exacerbations. Am. J. Respir. Crit."/>
 <result pre="viruses, symptoms, and inflammatory markers in acute exacerbations and stable" exact="chronic obstructive pulmonary disease." post="Am. J. Respir. Crit. Care Med. 164 1618– 1623"/>
 <result pre="Effect of exacerbation on quality of life in patients with" exact="chronic obstructive pulmonary disease." post="Am. J. Respir. Crit. Care Med. 157 1418– 1422"/>
 <result pre="F. ( 2002). New strains of bacteria and exacerbations of" exact="chronic obstructive pulmonary disease." post="N. Engl. J. Med. 347 465– 471 10.1056/NEJMoa012561 12181400"/>
 <result pre="F. ( 2008). Infection in the pathogenesis and course of" exact="chronic obstructive pulmonary disease." post="N. Engl. J. Med. 359 2355– 2365 10.1056/NEJMra0800353 19038881"/>
 <result pre="65 10.1378/chest.126.1.59 15249443 Tan W. C. ( 2005). Viruses in" exact="asthma" post="exacerbations. Curr. Opin. Pulm. Med. 11 21– 26 15591884"/>
 <result pre="patients hospitalized with near-fatal asthma, acute exacerbations of asthma, or" exact="chronic obstructive pulmonary disease." post="Am. J. Med. 115 272– 277 10.1016/S0002-9343(03)00353-X 12967691 Tashkin"/>
 <result pre="et al. ( 2008). A 4-year trial of tiotropium in" exact="chronic obstructive pulmonary disease." post="N. Engl. J. Med. 359 1543– 1554 10.1056/NEJMoa0805800 18836213"/>
 <result pre="9315789 Tokuda Y. Miyagi S. ( 2007). Physical diagnosis of" exact="chronic obstructive pulmonary disease." post="Intern. Med. 46 1885– 1891 10.2169/internalmedicine.46.0455 18057759 Vallet C."/>
 <result pre="et al. ( 2009). Human bocavirus: a cause of severe" exact="asthma" post="exacerbation in children. J. Pediatr. 155 286– 288 10.1016/j.jpeds.2009.01.069"/>
 <result pre="E. Aksamit T. R. ( 2001). Diagnosis and treatment of" exact="allergic bronchopulmonary aspergillosis." post="Mayo Clin. Proc. 76 930– 938 10.1016/S0025-6196(11)62114-9 11560305 Vogelmeier"/>
 <result pre="Ansari Z. Stockley R. A. ( 2008). The prevention of" exact="chronic obstructive pulmonary disease" post="exacerbations by salmeterol/fluticasone propionate or tiotropium bromide. Am. J."/>
 <result pre="Gibbs R. L. et al. ( 1999). Evidence that severe" exact="asthma" post="can be divided patholo{-}gically into two inflammatory subtypes with"/>
 <result pre="syncytial virus, airway inflammation, and FEV1 decline in patients with" exact="chronic obstructive pulmonary disease." post="Am. J. Respir. Crit. Care Med. 173 871– 876"/>
 <result pre="2005). Human metapneumovirus infection plays an etiologic role in acute" exact="asthma" post="exacerbations requiring hospitalization in adults. J. Infect. Dis. 192"/>
 <result pre="10.1186/1710-1492-4-3-111 20525132 Xepapadaki P. Papadopoulos N. G. ( 2010). Childhood" exact="asthma" post="and infection: virus-induced exacerbations as determinants and modifiers. Eur."/>
 <result pre="2012). Reduced rhinovirus-specific antibodies are associated with acute exacerbations of" exact="chronic obstructive pulmonary disease" post="requiring hospitalisation. BMC Pulm. Med. 12: 37 10.1186/1471-2466-12-37% Abbreviations"/>
 <result pre="requiring hospitalisation. BMC Pulm. Med. 12: 37 10.1186/1471-2466-12-37% Abbreviations ABPA" exact="allergic bronchopulmonary aspergillosis" post="AdVs adenoviruses BAL bronchoalveolar lavage COPD chronic obstructive lung"/>
 <result pre="BMC Pulm. Med. 12: 37 10.1186/1471-2466-12-37% Abbreviations ABPA allergic bronchopulmonary" exact="aspergillosis" post="AdVs adenoviruses BAL bronchoalveolar lavage COPD chronic obstructive lung"/>
 <result pre="bronchopulmonary aspergillosis AdVs adenoviruses BAL bronchoalveolar lavage COPD chronic obstructive" exact="lung disease" post="CRP C-reactive protein FEV 1.0 forced expiratory volume in"/>
 <result pre="volume in 1 second GOLD Global initiative for chronic obstructive" exact="lung disease" post="HMPV human metapneumovirus HRV human rhinovirus ICS inhaled corticosteroid"/>
</results>
